Abstract Bacteriophages infecting Staphylococcus epidermidis were isolated by mitomycin C induction. Three distinct phages (vB_SepiS-phiIPLA5, vB_SepiS-phiIPLA6, and vB_SepiS-phiIPLA7)-defined by plaque morphology, structure, virion proteins pattern, DNA restriction bands, and host range-were obtained. One-step growth curves of bacteriophages under optimal growth conditions for S. epidermidis F12 revealed eclipse and latent periods of 5-10 and 10-15 min, respectively, with burst sizes of about 5 to 30 PFU per infected cell. Transmission electron microscopy revealed that the phages were of similar size and belonged to the Siphoviridae family. Phage phi-IPLA7 had the broadest host range infecting 21 out of 65 S. epidermidis isolates. Phage phi-IPLA5 seemed to be a virulent phage probably derived from phi-IPLA6. Phages phi-IPLA5 and phi-IPLA7 exhibited increasing plaques surrounded by a halo that could be indicative of a polysaccharide depolymerase activity. Viable counts, determined during the infection of S. epidermidis F12, confirmed that phi-IPLA5 had a potent lytic capability and reduced S. epidermidis population by 5.67 log units in 8 h of incubation; in the presence of the mixture of phi-IPLA6 and phi-IPLA7, however, a reduction of 2.27 log units was detected
Introduction
Staphylococcus epidermidis was previously regarded as an innocuous commensal microorganism on the human skin. However, this bacterium is now seen as an important opportunistic pathogen involved in balancing epithelial microbiota and as a major cause of nosocomial infections. This microorganism predominantly colonizes the mucous membranes as well as the cutaneous system of human body, but it can also cause infections in immunocompromised individuals, in patients with implanted medical devices or even in healthy women, where the staphylococci penetrate cutaneous and mucosal barriers [5, 12, 18] . In the animal health context, S. epidermidis remains as one of the most commonly isolated bacteria responsible for bovine mastitis [15] .
Biofilm formation is a key factor in the infection process and is considered the most important virulence factor of S. epidermidis. It allows the adhesion to host tissues and increases antibiotic tolerance [16] . The widespread use of various antimicrobial agents, including penicillins, macrolides, aminoglycosides, and semisynthetic penicillins such as methicillin, has led to the emergence of multipledrug-resistant S. epidermidis strains [8] . Furthermore, the ubiquity of S. epidermidis as a human commensal microorganism renders this bacterium an optimal carrier and reservoir for antibiotic resistance genes [17] . As a result, there is a renewed interest to discover other natural antimicrobial agents as an alternative or supplementary treatment for infectious diseases.
Bacteriophages have very effective bactericidal activity and several advantages over other antimicrobial agents. Most notably, phages replicate at the expense of infectious bacteria are available in abundance where they are most required, and so far, no serious or irreversible side effects of phage therapy have been described [20] . Although there are no phage therapy products in the Western countries market at the moment, numerous companies have developed or are in the process of developing phage-based products against Pseudomonas and Staphylococcus aureus infections [13, 22] . Bacteriophages have also been used to reduce the catheter-associated biofilms of S. epidermidis strains [3] .
To date, bacteriophages infecting S. epidermidis had been exclusively used for typing S. epidermidis strains [21] . As such, the complete genome and molecular characterization of only two bacteriophages have been reported [4] . Based on the scarce knowledge on S. epidermidis bacteriophages and the future prospects of phage therapy against this microorganism, the purpose of this study was to isolate and characterize novel phages able to infect S. epidermidis and to determine their lytic ability under lab-controlled conditions.
Materials and Methods

Bacterial Strains and Growth Conditions
Sixty-five S. epidermidis strains were isolated from women's breast milk [5] , with 41 of them suffering infectious mastitis (Table 1) . Staphylococcal cells were isolated in Agar Baird Parker (BP) and routinely cultured in TSB broth (Triptona Soy Broth, Scharlau) at 37°C with shaking or in TSB plates containing 2% (w/v) bacteriological agar (TSA).
Bacteriophage Isolation
Strains were grown to exponential phase and subsequently induced by adding mitomycin C (0.5 lg/ml). After incubation at 37°C for 3 h with shaking, induced cultures were centrifuged at 16,1009g for 5 min and the supernatants were filtered. The supernatants (5 ll) were spotted into agar overlay lawns of all the staphylococcal strains and monitored for zones of clearing. Plaques were re-isolated, propagated, and stored at -80°C in SM buffer (20 NaCl, pH 7.5) containing 50% glycerol (vol/vol). Concentrated and purified phage preparations were obtained from 1 liter of S. epidermidis F12 which was infected with the different phages at a multiplicity of infection (MOI) of 1. The infected cultures were then incubated for 3 h at 37°C with vigorous shaking. Phages were further purified by a CsCl continuous density gradient [19] .
Bacteriophage Host Range
The host range of phages was determined by the spot test. 5 ll of concentrated phage lysate ([10 9 PFU ml -1 ) was dropped onto a TSB plate overlaid with S. epidermidis (10 8 CFU ml -1 ). The host range was confirmed by the plaque assay. A 0.1 ml volume of stationary-phase host culture (10 8 CFU ml -1 ) was mixed with several dilutions of individual phage suspensions in 3 ml of molten TSB top agar (0.7% agar) and the mixture was poured on TSA plates. Efficiency of plaque formation (EOP) of selected phages was determined by dividing the phage titer on the test strain by the phage titer on the reference strain S. epidermidis F12. This strain was selected because it is infected by all the isolated phages.
Single-Step Growth Curve
A standardized protocol [9] was adapted for the S. epidermidis phages. Curves were performed in TSB broth supplemented with Ca(NO 3 ) 2 (10 mmol l -1 ) and MgSO 4 (10 mmol l -1 ) using a MOI of 0.1. A mid-exponentialphase culture (10 ml) of S. epidermidis F12 (OD 600nm = 0.1) was harvested by centrifugation and suspended into 0.1 volume of fresh TSB (ca. 10 7 CFU ml -1 ). The phage was added and allowed to adsorb for 10 min at 37°C. The mixture was then centrifuged, pelleted cells were resuspended into 10 ml of TSB, and incubation continued at 37°C. Two set of samples were first taken at 5-min intervals for a period of 30 min, and subsequently at 15-min intervals. The first set of samples was immediately diluted and plated for phage titration. To determine the eclipse period, a second set of samples was treated with 1% (vol/vol) chloroform to release intracellular phages before phage titration.
Temperate Versus Lytic Phage Determination
To determine whether a phage was temperate, putative lysogens (resistant to infection) were isolated as previously described [7] . Briefly, isolated colonies were recovered from lysis plaques and challenged with the corresponding phage to confirm resistance. Additionally, induction with mitomycin C further corroborated the presence of the prophage.
Electron Microscope Examination
Phage particles were negatively stained with 2% uranyl acetate, and electron micrographs were taken using a JEOL 12.000 EXII transmission electron microscope (JEDL USA Inc, Peabody, MA, USA).
Bacteriophage DNA Isolation and Restriction
Phage DNA was extracted by treatment of pure stocks as previously described [19] . DNA was digested with restriction enzymes according to the supplier instructions (Takara Bio Inc., Japan). Proteomic Analysis of Virion Proteins Phage structural proteins were extracted, purified as described [6] and analyzed by SDS-PAGE as described by Laemli [11] in a Miniprotean III (Bio-Rad, Richmond, CA) at a constant current of 30 mA. After electrophoresis, the gels were either stained with Coomassie R-250 blue or silver (Silver staining kit, protein, GE Healthcare Piscataway, NJ, USA).
Bacteria-Phage Challenge Test Against S. epidermidis
The bactericidal effect of phages on S. epidermidis F12 was observed by determining bacteria viable counts throughout the incubation period. 10 ml of TSB broth were inoculated with 1% (vol/vol) overnight S. epidermidis F12 culture and incubated at 37°C with shaking until it reached early logarithmic phase (OD 600nm = 0.1) (10 7 CFU ml -1 ). A 100-fold dilution of the culture (10 5 CFU ml -1 ) was infected and incubated to 37°C. Phages were added at indicated MOIs, and viable cells and phage titer were monitored at 2 h intervals for 8 h.
Results and Discussion
Isolation of S. epidermidis Bacteriophages
Based on the renewed interest in phage therapy and the success of a number of recent animal experiments conducted with viable phage particles as antibacterial agents, we aimed to isolate phages which could be tentatively useful as novel strategies to combat S. epidermidis infections. As potential hosts, several S. epidermidis strains of human origin [5] were selected ( Table 1) . Out of 65 genetically-diverse strains, 41 were isolated from the breast milk of women suffering from mastitis infection and 24 were isolated from healthy women. These two S. epidermidis populations clustered mainly into two distinct PFGE profiles, matching with the origin of the strains, and with pathogenic strains showing higher biofilm production and resistance to antibiotics [5] . All the attempts to isolate bacteriophages infecting S. epidermidis strains from environmental samples such as breast milk of healthy and mastitic women, skin and mucous surface exudates were unsuccessful (data not shown). Consequently, mitomycin C induction of S. epidermidis strains was performed and the presence of bacteriophages in the culture supernatants tested. Two phages-phi-IPLA6 and phi-IPLA7-were isolated from S. epidermidis DD2Laa and S. epidermidis AEA1 strains, respectively. Furthermore, when the bacteriophage phi-IPLA6 was propagated on a lawn of S. epidermidis F12, some clear lysis plaques were observed. The Table 1 continued S. epidermidis plaques were further purified and the putative lytic phage was named phi-IPLA5. Based on these results, the yield of mitomycin C inducible prophages in S. epidermidis is rather low (3%). However, the apparently low presence of prophages could be due to the lack of appropriate sensitive host strains to detect them. Therefore, it would be premature to anticipate a low prophage content in this particular species.
Host Range of the Isolated Bacteriophages
The ability of new isolated phages to lyse pathogenic and commensal S. epidermidis strains was assayed by the spot test (Table 1) . Phage suspensions produced an inhibition halo on 25 out of the 65 strains tested. However, plaques were not always observed when the phage suspensions were serially diluted. For example, phage phi-IPLA5 inhibited 17 strains but clear plaques were only observed on five of them. The same thing occurred with the other two phages. This result could be explained by the effect of ''lysis from without'' caused by phages at high multiplicities of infection (MOI). In this case, cell lysis is produced by peptidoglycan hydrolases present in the mature virions of some phages [14] . These muralytic activities locally degrade the peptidoglycan of the host cell in order to facilitate the entry of phage DNA during infection. Besides the distinct host range, the individual S. epidermidis phages showed differences up to 6 orders of magnitude in their infection effectiveness against sensitive S. epidermidis strains as judged by EOP. Furthermore, plaques formed by phages phi-IPLA6 and phi-IPLA7 were turbid while clear plaques in all sensitive strains were obtained with phi-IPLA5 (data not shown). Among the strains, only three (S. epidermidis F12, LCO17, and LV5RB3) were sensitive to the three bacteriophages and lysis plaques were observed (Table 1 ). Resistance to these phages might be due to superinfecction immunity by resident prophages not detected during the screening with mitomycin C. In addition, bacteriophages usually show a narrow host range and actually they are commonly used for identification of closely related bacterial strains [21] . Owing to this, further experiments are needed to isolate new phages and combine them to create an optimal cocktail with broad activity against S. epidermidis strains.
Absence of Cross-Immunity Among Bacteriophages phi-IPLA5, phi-IPLA6, and phi-IPLA7
The lytic nature of phi-IPLA5 was experimentally confirmed because lysogenic bacteria could not be isolated (data not shown). On the contrary, lysogenic cultures carrying phi-IPLA6 and phi-IPLA7 phages could be generated. Lysogenized strains become immune to infection by similar phages and might hinder the use of phages as therapeutic agents. In order to minimize this trouble, the use of several phages belonging to a distinct immunity group is convenient. S. epidermidis F12-phi-IPLA6 was resistant to infection by phage phi-IPLA6 but was infected and lysed by phages phi-IPLA5 and phi-IPLA7. Likewise, S. epidermidis F12-phi-IPLA7 cells were immune to phi-IPLA7 but susceptible to phi-IPLA5 and phi-IPLA6 infection (data not shown). Based on these results, the temperate phages phi-IPLA6 and phi-IPLA7 belong to a distinct immunity group and, thus, suitable mixtures of these phages would prevent the development of lysogenic derivative strains.
Increasing Size on Lysis Plaques Surrounded by a Halo
An interesting result was that phages phi-IPLA5 and phi-IPLA7 showed lysis plaques surrounded by halos that increased along longer incubations. These lysis plaques increased in size when they were kept on the lab bench for 240 h (Fig. 1) . Phage phi-IPLA5 plaques increased by 1.5 mm in 120 h while phi-IPLA7 plaques were 3 mm larger after 168 h. The plaque expansion and the presence of halos could be indicative of soluble enzymes degrading extracellular polymeric structures such as exopolysaccharides from the host strain. Previous studies have showed that certain Klebsiella pneumoniae and Enterobacter agglomerans phages synthesised an enzyme that was released from the infected bacteria during plaque formation [10] . Phages producing depolymerases have biotechnological applications as treatments to prevent or control infectious biofilms [3] . Therefore, considering that S. epidermidis is able to produce biofilms, identification of the putative depolymerase activity in phages phi-IPLA5 and phi-IPLA7 deserves further investigation. Time (hours) Lysis plaques diameter (mm) Fig. 1 Evolution of the plaque size throughout time on a lawn of S. epidermidis F12 at room temperature. Filled circle phage phi-IPLA5, filled square phage phi-IPLA6, and filled triangle phage phi-IPLA7. Diameter values were expressed as the average of 85 plaques measurements Single-Step Growth Curve
The proliferation rate of bacteriophages is usually determined by the latent period and the burst size. Both parameters can be calculated from the one-step growth curves. Data obtained from bacteriophages phi-IPLA5, phi-IPLA6, and phi-IPLA7 propagated on S. epidermidis F12 showed similar eclipse and latent periods (Fig. 2) . The burst sizes ranged from 5 to 30 PFU per infected cell under the assay conditions. No data are available in other S. epidermidis phages; they were, however, similar to that for Staphylococcus aureus phages [7] .
Morphology of Phage Particles
Concentrated and purified solutions of phages phi-IPLA5, phi-IPLA6, and phi-IPLA7 were examined by electron microscopy (Fig. 2) . A number of shared features were observed: an isometric capsid, a long and narrow noncontractil tail, as well as the presence of both a baseplate and short tail fibers. Based on its morphology, these bacteriophages belong to the family Siphoviridae. The diameters of the capsids (means ± standard deviations) of phi-IPLA5, phi-IPLA6, and phi-IPLA7 were, respectively, 53.04 ± 4.95, 47.42 ± 6.27, and 53.08 ± 10.66 nm. The tail of phi-IPLA5 had a length of 144.51 ± 10.07 nm and width of 13.07 ± 2.08 nm, and was the largest compared to phi-IPLA6 (135.87 ± 9.58 nm long and 12.54 ± 1.66 nm wide) and phi-IPLA7 (136.68 ± 8.68 nm long and 9.81 ± 0.87 nm wide) tails.
SDS-PAGE and Genetic Analysis of Bacteriophages
In phage phi-IPLA5 four structural proteins were observed, and the most abundant polypeptide had a molecular mass about 34 kDa. Two polypeptides with molecular masses of about 30 and 34 kDa were observed in phi-IPLA6. Finally, two main bands (27.5 and 34 kDa) and at least three other polypeptide bands ranging from ca. 21 to 76 kDa were also detected in phi-IPLA7 (Fig. 3a) . These bands, which were easily detected, were most likely the major head and tail proteins. In order to examine whether phages were genetically different, restriction analyses of their genomic DNA were performed. The estimated sizes of the full-length phage genomes of phi-IPLA5, phi-IPLA6, and phi-IPLA7 were, respectively, 39, 38, and 33 kb. The restriction patterns of the phi-IPLA7 genome were unique (Fig. 3d) . By contrast, phages phi-IPLA5 and phi-IPLA6 appeared to be very closely related as the restriction profiles were very similar. The only significant difference resided in the absence of PstI fragments in phi-IPLA6 (Fig. 3b, c) . However, as has been showed above, phage phi-IPLA5 was able to infect the lysogenic strain S. epidermidis F12-phi-IPLA6. Thus, it could be speculated that phi-IPLA5 is a virulent derivative from phi-IPLA6, i.e., a phage able to overcome superinfection immunity. Point mutations in the operator regions could inhibit the specific binding of the resident prophage repressor which allows the replication of the infecting phage [2] .
Bacteriophage Inhibition of S. epidermidis F12 Growth
Preliminary challenge trials were performed to evaluate the potential of the isolated phages as antimicrobials against S. epidermidis. The mixture of the temperate phages phi-IPLA6 and phi-IPLA7 was used at MOI = 10 to infect S. epidermidis F12 (Fig. 4a) . Within the first 4 h, viable counts were similar to phage-infected and uninfected (control) cultures, and staphylococcal proliferation was prevented afterward. S. epidermidis counts were reduced by 2.27 log units compared with the control cultures (Fig. 4a) . Furthermore, viable bacteria were still at 10 6 CFU ml -1 at 24 h (data not shown). It was expected that the addition of a mixture of the two temperate phages to S. epidermidis cultures would suppress bacterial growth and even fully lyse the host culture since they do not belong to the same immunity group. However, even though phage multiplication took place, the phage mixture failed to completely eliminate the host cells. It is possible that the proper phage:bacteria host ratio was not reached under these experimental conditions [1] . S. epidermidis F12 was also infected with the lytic phage phi-IPLA5 at MOI = 150. A similar trend of viable bacteria was observed within the first 2 h. The infected cultures stopped growing for the next 4 h and then viable counts dropped drastically. At the end of the incubation period, a difference of 5.67 log units was observed between phage-infected and control cultures (Fig. 4b) . This result supports the ''general'' assumption that lytic phages would be more suitable for phage therapy. Nevertheless, in a phage therapy context, further characterization of these newly isolated S. epidermidis phages will be carried out as a pre-requisite to examine their safety, i.e., absence of virulent traits. Moreover, genome mining might reveal novel lytic proteins and, hopefully, other relevant antimicrobials active in biofilms such as depolymerases.
